| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00213-002-1362-1 |
| P698 | PubMed publication ID | 12589526 |
| P50 | author | Marcelo O Dietrich | Q39272573 |
| Diogo O Souza | Q39272593 | ||
| P2093 | author name string | Diogo R Lara | |
| Oscar P Dall'Igna | |||
| Ricardo V de Oliveira | |||
| Anselmo Hoffmann | |||
| Adriana L Da Silva | |||
| P2860 | cites work | Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats | Q67522551 |
| Characteristics of the ambulation-increasing effect of the noncompetitive NMDA antagonist MK-801 in mice: assessment by the coadministration with central-acting drugs | Q68227838 | ||
| The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice | Q69335069 | ||
| Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity | Q70375369 | ||
| Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens | Q71353673 | ||
| Dopamine-independent and adenosine-dependent mechanisms involved in the effects of N-methyl-D-aspartate on motor activity in mice | Q72348706 | ||
| Schizophrenia: a purinergic hypothesis | Q73735508 | ||
| Adenosine A1 and A2 receptor agonists significantly prevent the electroencephalographic effects induced by MK-801 in rats | Q73740408 | ||
| Lack of NMDA receptor involvement in caffeine-induced locomotor stimulation and tolerance in rats | Q74225833 | ||
| Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors | Q28204434 | ||
| Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats | Q28280906 | ||
| Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice | Q28373098 | ||
| Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. | Q31804337 | ||
| Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment. | Q31997655 | ||
| Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. | Q33537215 | ||
| Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity | Q34110463 | ||
| NMDA receptors and learning and memory processes | Q34367714 | ||
| The neurobiological basis of spontaneous alternation | Q34522654 | ||
| Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors | Q36670129 | ||
| Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats | Q43614893 | ||
| Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats | Q43974721 | ||
| Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens | Q44085141 | ||
| The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects | Q44177823 | ||
| Release of adenosine by activation of NMDA receptors in the hippocampus. | Q45964014 | ||
| The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. | Q48218273 | ||
| N‐Methyl‐d‐Aspartate‐ and Non‐N‐Methyl‐d‐Aspartate‐Evoked Adenosine Release from Rat Cortical Slices: Distinct Purinergic Sources and Mechanisms of Release | Q48329970 | ||
| Levels of endogenous adenosine in rat striatum. II. Regulation of basal and N-methyl-D-aspartate-induced levels by inhibitors of adenosine transport and metabolism | Q48473280 | ||
| A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. | Q48658263 | ||
| Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex | Q48728126 | ||
| Interactive effects of subanesthetic ketamine and haloperidol in healthy humans | Q48746210 | ||
| Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction | Q49162773 | ||
| Stereoselective Antagonism of Phencyclidine's Discriminative Properties by Adenosine Receptor Agonists | Q51859240 | ||
| The adenosine A1 receptor agonist N6-cyclopentyladenosine blocks the disruptive effect of phencyclidine on prepulse inhibition of the acoustic startle response in the rat. | Q51985129 | ||
| Sequential involvement of NMDA receptor-dependent processes in hippocampus, amygdala, entorhinal cortex and parietal cortex in memory processing. | Q52046814 | ||
| The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. | Q52049379 | ||
| Effects of dopamine depletion on the morphology of medium spiny neurons in the shell and core of the rat nucleus accumbens. | Q52913917 | ||
| Purine modulation of dizocilpine effects on spontaneous alternation | Q58852571 | ||
| Effect of N-methyl-d-aspartate on motor activity and in vivo adenosine striatal outflow in the rat | Q60050264 | ||
| Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic | Q60050265 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 258-263 | |
| P577 | publication date | 2003-02-13 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice | |
| P478 | volume | 166 |
| Q44645833 | Adenosine A1 Receptor Agonists Block the Neuropathological Changes in Rat Retrosplenial Cortex after Administration of the NMDA Receptor Antagonist Dizocilpine |
| Q30457808 | Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy |
| Q49182621 | Caffeine Neuroprotective Mechanism Against β-Amyloid Neurotoxicity in SHSY5Y Cell Line: Involvement of Adenosine, Ryanodine, and N-Methyl-D-Aspartate Receptors |
| Q46191307 | Caffeine, adenosine receptors, memory and Alzheimer disease |
| Q43198404 | Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice |
| Q34558887 | Cinnarizine has an atypical antipsychotic profile in animal models of psychosis. |
| Q30364369 | Concentration- and age-dependent effects of chronic caffeine on contextual fear conditioning in C57BL/6J mice. |
| Q50900600 | Effects of activation and blockade of NMDA receptors on the extinction of a conditioned passive avoidance response in mice with different levels of anxiety. |
| Q57792885 | Effects of chronic caffeine consumption on sleep and the sleep electroencephalogram in mice |
| Q48089404 | Investigation into effects of antipsychotics on ectonucleotidase and adenosine deaminase in zebrafish brain |
| Q34615473 | Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness |
| Q30457807 | Mouse pharmacological models of cognitive disruption relevant to schizophrenia |
| Q39430303 | Synergistic antidepressant-like effect of the joint administration of caffeine and NMDA receptor ligands in the forced swim test in mice |
| Q46681825 | Toluene exposure during the brain growth spurt reduces behavioral responses to noncompetitive N-methyl-D-aspartate receptor antagonists in adult rats |
| Q47868325 | Transient Disruption of Adenosine Signaling During Embryogenesis Triggers a Pro-epileptic Phenotype in Adult Zebrafish |
Search more.